alexion.com is a domain
that was created on 1995-08-16,making it 29 years ago.
It has several subdomains, such as ir.alexion.com
news.alexion.com , among others.
Description:Alexion is a global biopharmaceutical company focused on developing life-changing therapies for people living with rare...
Keywords:alexion...
Discover alexion.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site
HomePage size: 77.55 KB |
Page Load Time: 0.929953 Seconds |
Website IP Address: 13.224.189.46 |
Press Releases | Alexion Pharmaceuticals, Inc. |
Press Releases | Alexion Pharmaceuticals, Inc. |
Alexion https://alexion.com/ |
Legal Statement https://alexion.com/Legal |
Alexion Pharmaceuticals, Inc.: Press Releases, Featured ... http://media.alexion.com/ |
Austria Operations https://alexion.com/worldwide/Austria |
Italy Operations https://alexion.com/worldwide/Italy |
Norway Operations https://alexion.com/worldwide/Norway |
Alexion Australia https://alexion.com/worldwide/Australia |
France Operations https://alexion.com/worldwide/France |
Belgium Operations https://alexion.com/worldwide/Belgium |
UAE Operations https://alexion.com/worldwide/UAE |
A alexion.com. 60 IN A 13.224.189.75 |
MX alexion.com. 300 IN MX 1 de-smtp-inbound-1.mimecast.com. |
NS alexion.com. 21600 IN NS ns-1319.awsdns-36.org. |
TXT alexion.com. 300 IN TXT 1a348noueuphnfjm5cs5ccms6k |
SOA alexion.com. 900 IN SOA ns-89.awsdns-11.com. awsdns-hostmaster.amazon.com. 2016070801 7200 900 1209600 86400 |
Content-Type: text/html; charset=utf-8 |
Content-Length: 82165 |
Connection: keep-alive |
Vary: Accept-Encoding |
Cache-Control: no-cache, no-store, no-cache="set-cookie" |
Date: Tue, 14 May 2024 08:40:33 GMT |
e: 10B |
ei: PRD-CD-1A01 |
Expires: -1 |
Pragma: no-cache |
Server: Microsoft-IIS/10.0 |
Set-Cookie: shell#lang=en; path=/; secure; SameSite=None, ASP.NET_SessionId=m10etxnhbxivzufdoyxv54vt; path=/; secure; HttpOnly; SameSite=None, AWSELB=1757C11D02A92F9794A6CAE3DFAEB995950A7588223F4DBA2A5CDAFFE9084D9C305E2970668BE7DEA6AB13E3BF4EC417B4E8BAE128FB164C20148D51A9CABA161A23BD26E9;PATH=/;MAX-AGE=14400 |
x-frame-options: sameorigin |
X-Cache: Miss from cloudfront |
Via: 1.1 3bcf22eea36ee98708782266e5ad21d6.cloudfront.net (CloudFront) |
X-Amz-Cf-Pop: YVR52-P2 |
X-Amz-Cf-Id: n3SomebH558UpHvfkSQ5kI8m_c5BV1eGdmAqCM_GuEJ4JJmz1tgUYA== |
charset="utf-8"/ |
content="ie=edge" http-equiv="x-ua-compatible"/ |
content="Alexion" property="og:title" |
content="Alexion" name="twitter:title"/ |
content="alexion" name="keywords" |
content="Alexion is a global biopharmaceutical company focused on developing life-changing therapies for people living with rare disorders." name="description" |
content="Alexion is a global biopharmaceutical company focused on developing life-changing therapies for people living with rare disorders." property="og:description"/ |
content="Alexion is a global biopharmaceutical company focused on developing life-changing therapies for people living with rare disorders." name="twitter:description"/ |
content="minimal-ui, width=device-width, initial-scale=1.0, maximum-scale=1.0, user-scalable=no" name="viewport" |
content="index,follow" name="robots"/ |
content="yes" name="apple-mobile-web-app-capable"/ |
content="black" name="apple-mobile-web-app-status-bar-style"/ |
content="320" name="MobileOptimized"/ |
content="/ms-icon-144x144.png" name="msapplication-TileImage"/ |
content="/ms-icon-70x70.png" name="msapplication-square70x70logo"/ |
content="/ms-icon-150x150.png" name="msapplication-square150x150logo"/ |
content="/ms-icon-310x150.png" name="msapplication-wide310x150logo"/ |
content="/ms-icon-310x310.png" name="msapplication-square310x310logo"/ |
content="https://alexion.com" property="og:url"/ |
content="en_US" property="og:locale"/ |
content="http://alexion.com//~/media/Alexion_comRedesign/Images/Logos/Alexion_logo_RGB_OG.svg" property="og:image"/ |
content="website" property="og:type"/ |
content="https://alexion.com" property="og:site_name"/ |
content="http://alexion.com//~/media/Alexion_comRedesign/Images/Logos/Alexion_logo_RGB_OG.svg" name="twitter:image"/ |
content="summary_large_image" name="twitter:card"/ |
Ip Country: United States |
Latitude: 37.751 |
Longitude: -97.822 |
’) MAKING A MEANINGFUL IMPACT FOR PEOPLE LIVING WITH RARE DISEASES, EVERYDAY Learn how we are taking bold steps to improve health equity for people living with rare diseases.Investors News & Media Contact Us Worldwide North America Latin America Europe & The Middle East Asia Pacific Canada (English) Canada (French) United States Brazil Colombia Austria Belgium Denmark France Germany Ireland Italy (English) Italy (Italian) Netherlands Norway Spain Sweden Switzerland Turkey UAE United Kingdom Australia China Japan Our Inspiration Living With Rare Diseases Real Stories NF1 aHUS gMG HPP LAL-D NMOSD PNH Support Services Albie, one of our guiding stars When Albie was born, his mom, Charlotte, said that he was absolutely fine. Everything was fine for about two weeks.” Our Medicines Conditions We Treat aHUS gMG HPP LAL-D NF1 PN NMOSD PNH Medicines Our medicines help people like Donnan As a father of two young children, Donnan recalls being afraid of what the future would hold prior to his diagnosis. Our Research Research and Development Our Science Pipeline Research Partnerships Discovery Partnerships Externally Sponsored Research We innovate for Ruthie Married with a newborn son, Ruthie was scared to learn that PNH was a life-threatening illness that at the time had no approved treatment. Our Commitment Corporate Social Responsibility Charitable Foundation Managed Access Programs COVID-19 We give back for families like Evie’s At only three months old, Evie’s parents were told that her case was severe and that there were no approved or effective treatment options. Our CompanyLeadership Inclusion & Diversity History Ethical Standards Quality Product Safety Roberta is our inspiration Despite having a constant struggle with symptoms, Roberta revisited her dreams and put herself through nursing school. Your Career Career Opportunities Join Our Team Working Here Benefits Culture Make a difference for families like Tristan’s Tristan’s parents experienced a whirlwind of emotions and fear after learning their 5-year-old son had such a rare and serious disease. Our Inspiration Living With Rare Diseases Real Stories NF1 aHUS gMG HPP LAL-D NMOSD PNH Support Services Our Medicines Conditions We Treat aHUS gMG HPP LAL-D NF1 PN NMOSD PNH Medicines Our Research Research and Development Our Science Pipeline Research Partnerships Discovery Partnerships Externally Sponsored Research Our Commitment Corporate Social Responsibility Charitable Foundation Managed Access Programs COVID-19 Our CompanyLeadership Inclusion & Diversity History Ethical Standards Quality Product Safety Your Career Career Opportunities Join Our Team Working Here Benefits Culture Investors News & Media Contact Us Worldwide North America Canada (English) Canada (French) United States Latin America Brazil Colombia Europe & The Middle East Austria Belgium Denmark France Germany Ireland Italy (English) Italy (Italian) Netherlands Norway Spain Sweden Switzerland Turkey UAE United Kingdom Asia Pacific Australia China Japan Inspired Every Day The work we do is guided by people living with rare and devastating diseases. We are driven to continuously innovate and create meaningful value in all we do to help patients and families fully live their best lives. SEE THEIR STORIES My hope for Tanner in the future is that he enters into adulthood. I kind of hope that he will be a doctor and maybe help kids like doctors have helped him.” RENE, MOM OF TANNER LIVING WITH HPP HEAR HIS STORY ABOUT HPP TANNER LIVING WITH HPP This experience has taught me to look at the small things that count. Now, I feel that I have something to look forward to and I am who I want to be.” ROBERTA LIVING WITH gMG HEAR HER STORY ABOUT gMG ROBERTA LIVING WITH GMG Now we knew what we were up against, we knew we could fight.” REBECCA, MOM OF TRENDY BROTHERS LIVING WITH LAL-D HEAR THEIR STORY ABOUT LAL-D THE TRENDY FAMILY LIVING WITH LAL-D I’m hoping my story will inspire others to continue to fight for themselves." KIM LIVING WITH NMOSD HEAR HER STORY ABOUT NMOSD KIM LIVING WITH NMOSD I can chase my kids and play again. I think knowing what I have brings a peace to my life.” DONNAN LIVING WITH aHUS HEAR HIS STORY ABOUT aHUS DONNAN LIVING WITH aHUS Every day, those who live with rare diseases and devastating conditions inspire us to push the boundaries of medicine, technology, and healthcare services. Our goal is to transform their reality for the better. 6 APPROVED MEDICINES 7 RARE DISEASES & DEVASTATING CONDITIONS 25+ OFFICES WORLDWIDE 3000+ TALENTED COLLEAGUES SEE HOW WE DO IT Everyday Stories Working Every Day for the Rare Disease Community At , AstraZeneca Rare Disease, we are committed to working with the patient community and health care stakeholders worldwide to address the challenges facing the rare disease community. Together, on Rare Disease Day — and every day — we can make a powerful difference. Learn More FOLLOW US insta LATEST NEWS MORE NEWS The World Health Organization estimates that one out of 15 people worldwide could be affected by a rare disease. For more information: https://bit.ly/2EhEfWG Generalized myasthenia gravis (#gMG) is a rare autoimmune disorder characterized by loss of muscle function and severe muscle weakness. For further advice and support: https://myasthenia.org/ #RareDisease We strive to ignite an inclusive environment where people belong because of their uniqueness and unleash their individuality and diversity to spur innovative breakthroughs for patients. Join us: https://jobs.alexion.com #hiring DYK… 80% of #RareDiseases are genetic, while others are the result of infection, allergies, and environmental causes, or are rare cancers. For more information and support, visit https://globalgenes.org/rare-disease-facts/ At , you’re encouraged to take on the most daunting of challenges, settle for nothing less than transformation, and push the boundaries of what science has traditionally offered. Check out our career opportunities: jobs.alexion.com #hiring This experience has taught me to look at the small things that count. Now, I feel that I have something to look forward to and I am who I want to be.” ROBERTA LIVING WITH gMG HEAR HER STORY × You are now leaving www.alexion.com, a website provided by Pharmaceuticals, Inc. This link will take you to a different site to which this Privacy Policy does not apply. CONFIRM CLOSE × You are now leaving the alexion.com UK webpage for the global alexion.com website. The content on the global site is intended for a U.S. audience only CONFIRM CLOSE MEDICAL PROFESSIONALS Conditions We Treat Medicines Pipeline The rare disease community Real Stories Living With Rare Diseases Support Services NEWS & MEDIA Press Releases Featured Stories Media Materials JOB SEEKERS Benefits Culture Working Here insta Contact Us Legal Statement Privacy Notice Terms of Use Cookie Settings Your Privacy Choices This website is intended only for residents of the United States. © 2022 Pharmaceuticals,...
Domain Name: ALEXION.COM Registry Domain ID: 2110304_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.corporatedomains.com Registrar URL: http://cscdbs.com Updated Date: 2024-05-17T17:37:58Z Creation Date: 1995-08-16T04:00:00Z Registry Expiry Date: 2030-08-15T04:00:00Z Registrar: CSC Corporate Domains, Inc. Registrar IANA ID: 299 Registrar Abuse Contact Email: domainabuse@cscglobal.com Registrar Abuse Contact Phone: 8887802723 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS-1319.AWSDNS-36.ORG Name Server: NS-1612.AWSDNS-09.CO.UK Name Server: NS-791.AWSDNS-34.NET Name Server: NS-89.AWSDNS-11.COM DNSSEC: unsigned >>> Last update of whois database: 2024-05-17T19:40:14Z <<<